Glycopyrrolate — Class I drug recall D-1252-2014
Terminated recall by Brookfield Prescription Center Inc, reported 2014-04-30, distributed in WI. Non-Sterility: One lot of Glycopyrrolate solution for injection was found to be contaminated with Bacillus thu
| Recall number | D-1252-2014 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Brookfield Prescription Center Inc, Brookfield, WI, United States |
| Recall initiated | 2013-11-13 |
| Classified | 2014-04-21 |
| Reported by FDA | 2014-04-30 |
| Terminated | 2014-05-30 |
| Distributed | WI |
| Quantity | 25 vials |
| Reason classes | sterility |
| Expiration dates | 2013-11-28 |
Product
Glycopyrrolate (MDV) 0.2 MG/ML Injectable, 5 mL Vials, Sterile Serum Vials/Sterile Syringes, for use by a licensed professional only, not for resale, MD Custom Rx, 19035 W Capitol Dr Ste 105, Brookfield, WI 53045.
Reason for recall
Non-Sterility: One lot of Glycopyrrolate solution for injection was found to be contaminated with Bacillus thuringiensis.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1252-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.